1. Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor-gamma agonist;Aleo;J. Pharmacol. Exp. Ther.,2003
2. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase;Arlt;J. Biol. Chem.,2001
3. Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor-α/γ agonist, on diabetic complications in Zucker Diabetic Fatty (ZDF) rats;Bénardeau;Diabetes,2011
4. Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes;Benardeau;Bioorg Med. Chem. Lett.,2009
5. Effects of aleglitazar, a dual PPAR-α/γ agonist, on lipid parameters in patients with type 2 diabetes: post hoc sub-analysis comparing patients with or without statins at baseline;Chognot;Diabetologia,2011